e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Inflammation and remodelling in allergy and asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
In vivo
and
in vitro
effects of variants of Parj2 in asthmatic children
E. Pace, G. Duro, S. La Grutta, M. Ferraro, R. Di Fiore, G. Chiappara, A. M. Montalbano, G. Bonsignore, M. Gjomarkaj (Palermo, Italy)
Source:
Annual Congress 2005 - Inflammation and remodelling in allergy and asthma
Session:
Inflammation and remodelling in allergy and asthma
Session type:
Oral Presentation
Number:
4190
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Pace, G. Duro, S. La Grutta, M. Ferraro, R. Di Fiore, G. Chiappara, A. M. Montalbano, G. Bonsignore, M. Gjomarkaj (Palermo, Italy).
In vivo
and
in vitro
effects of variants of Parj2 in asthmatic children. Eur Respir J 2005; 26: Suppl. 49, 4190
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Pharmacological characterization of the protective effect of mepolizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
Pharmacological characterization of the protective effect of benralizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
Effect of a novel inhaled glucocorticoid, ciclesonide, on an allergen-induced asthmatic response in rats and its prolonged anti-inflammatory activity in vitro
Source: Eur Respir J 2002; 20: Suppl. 38, 91s
Year: 2002
Increased release of cysteinyl-leukotrienes in
ex vivo
stimulated sputum cells from subjects with aspirin-intolerant asthma
Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases
Year: 2007
The effect of statin usage on airway inflammatiory cells and markers, and clinical indices in asthmatic patients
Source: Annual Congress 2011 - Asthma management and response
Year: 2011
Comparable efficacy of calcilytic and corticosteroid in short-term and long-term allergic asthma models in vivo
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018
Murine models of asthma
Source: Eur Respir J 2003; 22: 374-382
Year: 2003
Sputum cells profile and airway responsiveness in different asthma phenotypes in children
Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood
Year: 2010
MMP-9 gene variants increase the risk for non-atopic asthma in children
Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood
Year: 2010
Anti-oxidative and anti-inflammatory effects of Xanthorrhizol on aeroallergens-induced biological responses in vitro and ex vivo
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019
In vitro and in vivo studies of nanoparticles and the lung
Source: International Congress 2014 – Nanomaterials and respiratory health
Year: 2014
Effects of chronic exposure to IL-13 on mucociliary differentiation of epithelial cells obtained from asthmatic and non-asthmatic children
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009
Impact of particle exposure systems on acute effects in an in vitro alveolar model
Source: Virtual Congress 2021 – Occupational COVID-19 and respiratory infections
Year: 2021
Are there differences in the level of physical activity and functional capacity between healthy and asthmatic children and adolescents?
Source: International Congress 2019 – Asthma education: lifestyle and adolescence
Year: 2019
Identification of asthma phenotypes in children
Source: Breathe 2011; 8: 38-44
Year: 2011
The role of ACE gene polymorphisms in atopic bronchial asthma in children
Source: Annual Congress 2010 - Risk factors for allergic diseases in children
Year: 2010
The role of lung function measurements in identifying severe asthma in school-age children: results from a case-control study
Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children
Year: 2008
The effects of inhaled acid aerosol on lung function of asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 497s
Year: 2003
An in vitro method showing the atrophic effect of the COPD serum on healthy human myotubes
Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases
Year: 2019
Is asthma different in asthmatic siblings compared to asthmatics in general population?
Source: Eur Respir J 2004; 24: Suppl. 48, 167s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept